CLB FY 2008 Earnings Report — Core Laboratories N.V. Revenue & Financial Results | Market Cap Arena

Core Laboratories N.V.CLB

FY 2008 Earnings

Reported February 20, 2009

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2008	Prior Q	FY 2007	QoQ Change	YoY Change
Revenue	$781M	—	$671M	—	16.4%
Op. Income	$207M	—	$184M	—	12.4%
Gross Margin	34.1%	—	33.0%	—	1.1pp
Net Margin	18.4%	—	18.1%	—	0.3pp
EPS (Diluted)	$2.74	—	$2.48	—	10.5%
Free Cash Flow	$124M	—	$102M	—	22.0%

Revenue Flow

Item	Amount
REVENUE	$781M
Cost of Revenue	$515M
GROSS PROFIT	$266M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$32M
Other Expenses	$29M
Operating Expenses	$60M
Cost & Expenses	$575M
OPERATING INCOME	$207M
Interest Income	$848.0K
Interest Expense	$6M
Other Income/Expenses	$2M
INCOME BEFORE TAX	$209M
Income Tax Expense	$65M
Net Income from Continuing Ops	$132M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$144M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$131M
D&A	$22M
EBIT	$210M
EBITDA	$232M
EPS	$3
EPS Diluted	$3

Income Statement

Item	Amount
REVENUE	$781M
Cost of Revenue	$515M
GROSS PROFIT	$266M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$32M
Other Expenses	$29M
Operating Expenses	$60M
Cost & Expenses	$575M
OPERATING INCOME	$207M
Interest Income	$848.0K
Interest Expense	$6M
Other Income/Expenses	$2M
INCOME BEFORE TAX	$209M
Income Tax Expense	$65M
Net Income from Continuing Ops	$132M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$144M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$131M
D&A	$22M
EBIT	$210M
EBITDA	$232M
EPS	$3
EPS Diluted	$3

Cash Flow Statement

Item	Amount
Net Income	$144M
Depreciation & Amortization	$22M
Stock-Based Compensation	$5M
Deferred Income Tax	-$1M
Other Non-Cash Items	-$1M
Change in Working Capital	-$12M
OPERATING CASH FLOW	$155M
Capital Expenditure	-$31M
Acquisitions (Net)	-$12M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$30M
NET CASH FROM INVESTING	-$41M
Net Debt Issuance	-$56M
Common Stock Repurchased	-$32M
Common Dividends Paid	-$28M
Other Financing Activities	$12M
NET CASH FROM FINANCING	-$104M
FREE CASH FLOW	$124M
Net Change in Cash	$11M

Balance Sheet

Item	Amount
Cash & Equivalents	$36M
Short-Term Investments	$0
Net Receivables	$144M
Inventory	$35M
Other Current Assets	$0
TOTAL CURRENT ASSETS	$242M
PP&E (Net)	$103M
Goodwill	$149M
Intangible Assets	$7M
Long-Term Investments	$0
Tax Assets	$27M
Other Non-Current Assets	$9M
TOTAL NON-CURRENT ASSETS	$296M
TOTAL ASSETS	$538M
Account Payables	$42M
Short-Term Debt	$0
Deferred Revenue	$0
Other Current Liabilities	$18M
TOTAL CURRENT LIABILITIES	$96M
Long-Term Debt	$239M
Deferred Revenue NC	$8M
Deferred Tax Liabilities	$5M
Other Non-Current Liabilities	$30M
TOTAL NON-CURRENT LIABILITIES	$282M
TOTAL LIABILITIES	$377M
Common Stock	$1M
Additional Paid-In Capital	$53M
Retained Earnings	$406M
Treasury Stock	-$246M
Accum. Other Comp. Income	-$5M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$158M
Minority Interest	$2M
TOTAL EQUITY	$160M
TOTAL LIABILITIES & EQUITY	$538M
Total Debt	$239M
Net Debt	$203M